Perceptive Advisors LLC Ardelyx, Inc. Transaction History

Perceptive Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 14, 2018	SELL	$4.85 - $7.8 $6.56 Million - $10.5 Million	-1,352,391 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$4.35 - $5.7 $72.9 Million - $95.5 Million	-16,752,890 Reduced 92.53%	1,352,391 $7.57 Million
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.7 $78.8 Million - $103 Million	18,105,281	18,105,281 $10.1 Million

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.